Suppr超能文献

间充质干细胞衍生外泌体在癌症发展和靶向治疗中的作用

Roles of Mesenchymal Stem Cell-Derived Exosomes in Cancer Development and Targeted Therapy.

作者信息

Sun Zixuan, Zhang Jiaxin, Li Jiali, Li Mi, Ge Jing, Wu Peipei, You Benshuai, Qian Hui

机构信息

Zhenjiang Key Laboratory of High Technology Research on Exosomes Foundation and Transformation Application, School of Medicine, Jiangsu University, Zhenjiang 212013, China.

出版信息

Stem Cells Int. 2021 Jul 10;2021:9962194. doi: 10.1155/2021/9962194. eCollection 2021.

Abstract

Exosomes have emerged as a new drug delivery system. In particular, exosomes derived from mesenchymal stem cells (MSCs) have been extensively studied because of their tumor-homing ability and yield advantages. Considering that MSC-derived exosomes are a double-edged sword in the development, metastasis, and invasion of tumors, engineered exosomes have broad potential use. In this review, we focused on the latest development in the treatment of tumors using engineered and nonengineered MSC-derived exosomes (MSC-EXs). Nonengineered MSC-EXs exert an antitumor effect on several well-studied tumors by affecting tumor growth, angiogenesis, metastasis, and invasion. Furthermore, engineered exosomes have promising research prospects as drug-carrying tools for the transport of miRNAs, small-molecule drugs, and proteins. Although exosomes lack uniform standards in terms of definition, separation, and purification, they still have great research value because of their unique advantages, such as high biocompatibility and low toxicity. Future studies on MSC-EXs should elucidate the mechanisms underlying their anticancer effect and the safety of their application.

摘要

外泌体已成为一种新型药物递送系统。特别是,源自间充质干细胞(MSC)的外泌体因其肿瘤归巢能力和产量优势而受到广泛研究。鉴于MSC衍生的外泌体在肿瘤的发生、转移和侵袭过程中是一把双刃剑,工程化外泌体具有广泛的潜在用途。在本综述中,我们重点关注了使用工程化和非工程化MSC衍生的外泌体(MSC-EXs)治疗肿瘤的最新进展。非工程化MSC-EXs通过影响肿瘤生长、血管生成、转移和侵袭,对几种已深入研究的肿瘤发挥抗肿瘤作用。此外,工程化外泌体作为携带miRNA、小分子药物和蛋白质的药物载体工具具有广阔的研究前景。尽管外泌体在定义、分离和纯化方面缺乏统一标准,但由于其独特优势,如高生物相容性和低毒性,它们仍然具有很大的研究价值。未来关于MSC-EXs的研究应阐明其抗癌作用的潜在机制及其应用的安全性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fae0/8289580/f76ee9c33334/SCI2021-9962194.001.jpg

相似文献

1
Roles of Mesenchymal Stem Cell-Derived Exosomes in Cancer Development and Targeted Therapy.
Stem Cells Int. 2021 Jul 10;2021:9962194. doi: 10.1155/2021/9962194. eCollection 2021.
2
The potential applications of artificially modified exosomes derived from mesenchymal stem cells in tumor therapy.
Front Oncol. 2024 Jan 4;13:1299384. doi: 10.3389/fonc.2023.1299384. eCollection 2023.
3
Stem Cell Mimicking Nanoencapsulation for Targeting Arthritis.
Int J Nanomedicine. 2021 Dec 31;16:8485-8507. doi: 10.2147/IJN.S334298. eCollection 2021.
4
Mesenchymal stem cell (MSC)-derived exosomes as novel vehicles for delivery of miRNAs in cancer therapy.
Cancer Gene Ther. 2022 Aug;29(8-9):1105-1116. doi: 10.1038/s41417-022-00427-8. Epub 2022 Jan 26.
6
Gastric cancer and mesenchymal stem cell-derived exosomes: from pro-tumorigenic effects to anti-cancer vehicles.
Arch Pharm Res. 2024 Jan;47(1):1-19. doi: 10.1007/s12272-023-01477-8. Epub 2023 Dec 27.
7
Mesenchymal Stem Cell Derived Exosomes in Cancer Progression, Metastasis and Drug Delivery: A Comprehensive Review.
J Cancer. 2018 Aug 6;9(17):3129-3137. doi: 10.7150/jca.25376. eCollection 2018.
8
Mesenchymal stem cell-derived exosomes as new tools for delivery of miRNAs in the treatment of cancer.
Front Bioeng Biotechnol. 2022 Sep 26;10:956563. doi: 10.3389/fbioe.2022.956563. eCollection 2022.
9
Mesenchymal stem cell exosomes: a two-edged sword in cancer therapy.
Int J Nanomedicine. 2019 Apr 23;14:2847-2859. doi: 10.2147/IJN.S200036. eCollection 2019.

引用本文的文献

1
Therapeutic roles of natural and engineered mesenchymal stem cells and extracellular vesicles in atopic dermatitis.
Regen Ther. 2025 Jun 4;30:123-135. doi: 10.1016/j.reth.2025.05.009. eCollection 2025 Dec.
2
Mesenchymal Stem Cell-Derived Exosomes in Cancer Resistance Against Therapeutics.
Cancers (Basel). 2025 Feb 27;17(5):831. doi: 10.3390/cancers17050831.
3
Advancements in extracellular vesicles biomanufacturing: a comprehensive overview of large-scale production and clinical research.
Front Bioeng Biotechnol. 2025 Feb 19;13:1487627. doi: 10.3389/fbioe.2025.1487627. eCollection 2025.
4
Natural and Bioengineered Extracellular Vesicles in Diagnosis, Monitoring and Treatment of Cancer.
ACS Nano. 2025 Feb 18;19(6):5871-5896. doi: 10.1021/acsnano.4c11630. Epub 2025 Jan 27.
5
Mesenchymal stromal cell exosomes for drug delivery of prostate cancer treatments: a review.
Stem Cell Res Ther. 2025 Jan 23;16(1):18. doi: 10.1186/s13287-025-04133-8.
6
Different origin-derived exosomes and their clinical advantages in cancer therapy.
Front Immunol. 2024 Jun 27;15:1401852. doi: 10.3389/fimmu.2024.1401852. eCollection 2024.
7
Exosomes in diagnostic and therapeutic applications of ovarian cancer.
J Ovarian Res. 2024 May 25;17(1):113. doi: 10.1186/s13048-024-01417-0.
8
Therapeutic Applications of Stem Cell-Derived Exosomes.
Int J Mol Sci. 2024 Mar 21;25(6):3562. doi: 10.3390/ijms25063562.
9
Tumorigenic and tumoricidal properties of exosomes in cancers; a forward look.
Cell Commun Signal. 2024 Feb 15;22(1):130. doi: 10.1186/s12964-024-01510-3.
10

本文引用的文献

8
Extracellular vesicles: A bright star of nanomedicine.
Biomaterials. 2021 Feb;269:120467. doi: 10.1016/j.biomaterials.2020.120467. Epub 2020 Nov 6.
9
Isolation and characterization of exosomes for cancer research.
J Hematol Oncol. 2020 Nov 10;13(1):152. doi: 10.1186/s13045-020-00987-y.
10
Antitumor Activity of Cabazitaxel and MSC-TRAIL Derived Extracellular Vesicles in Drug-Resistant Oral Squamous Cell Carcinoma.
Cancer Manag Res. 2020 Oct 29;12:10809-10820. doi: 10.2147/CMAR.S277324. eCollection 2020.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验